SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001746473-24-000059
Filing Date
2024-04-22
Accepted
2024-04-22 17:00:13
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a2024.htm DEFA14A 11140
2 plianttherapeuticsinc_vxna.jpg GRAPHIC 507855
3 plianttherapeuticsinc_vxnaa.jpg GRAPHIC 370251
  Complete submission text file 0001746473-24-000059.txt   1221145
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39303 | Film No.: 24861866
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)